Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model.
Veldhuis. Johannes D JD; Keenan. Daniel M DM; Bowers. Cyril Y CY
Key Findings
- Post‑menopausal women secreted only about 27% of the GH burst amount that younger women did during fasting.
- Responses to GHRP‑2 (both bolus and constant) and other GH‑stimulating agents were 29‑42% lower in older women.
- The shape of GH bursts changed with age: l‑arginine caused a 160% longer time to peak, while bolus GHRP‑2 shortened the time to peak by 32%.
Practical Outcomes
- For biohackers using GHRP‑2 to boost GH, expect a markedly weaker effect in older women, regardless of estrogen supplementation. Adjust expectations or consider higher or more frequent dosing, but be aware that age also alters the timing of GH release, which may affect how you schedule dosing for optimal results.
Summary
The study shows that in healthy women, getting older sharply cuts down how much growth hormone (GH) is released in bursts, even when estrogen levels are kept constant. Both single shots and continuous infusions of GHRP‑2 (a GH‑releasing peptide) produce much smaller GH spikes in post‑menopausal women compared to younger women.
Abstract
Because estrogen production and age are strong covariates, distinguishing their individual impact on hypothalamo-pituitary regulation of growth hormone (GH) output is difficult. In addition, at fixed elimination kinetics, systemic GH concentration patterns are controlled by three major signal types [GH-releasing hormone (GHRH), GH-releasing peptide (GHRP, ghrelin), and somatostatin (SS)] and by four dynamic mechanisms [the number, mass (size), and shape (waveform) of secretory bursts and basal (time invariant) GH secretion]. The present study introduces an investigative strategy comprising 1) imposition of an experimental estradiol clamp in pre- (PRE) and postmenopausal (POST) women; 2) stimulation of fasting GH secretion by each of GHRH, GHRP-2 (a ghrelin analog), and l-arginine (to putatively limit SSergic restraint); and 3) implementation of a flexible-waveform deconvolution model to estimate basal GH secretion simultaneously with the size and shape of secretory bursts, conditional on pulse number. The combined approach unveiled the following salient percent POST/PRE contrasts: 1) only 27% as much GH secreted in bursts during fasting (P < 0.001); 2) markedly attenuated burstlike GH secretion in response to bolus GHRP-2 (29%), bolus GHRH (30%), l-arginine (37%), constant GHRP-2 (38%), and constant GHRH (42%) (age contrasts, 0.0016 </= P </= 0.027); and 3) a 160% prolongation and 32% abbreviation of the time required to achieve maximal GH secretion after injection of l-arginine and bolus GHRP-2, respectively (both, P < 0.001). Accordingly, age selectively determines both the size (amount) and shape (waveform) of GH secretory bursts in healthy women independently of the short-term estrogen milieu.
Study Information
pubmed
2007
2007-05-30T00:00:00.000Z
10.1152/ajpregu.00159.2007